Acute myeloid leukemia and myelodysplastic syndromes related to radiation

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Jan 2005

ThyroShield: FDA approved

For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

2

Total programs

2

Open now

2

Copay cards

Copay Assistance2

ThyroShield

Fleming & Company, Pharmaceuticals

OpenContact for details

AZACITIDINE

Pilnova Pharma Inc

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Reblozyl

(LUSPATERCEPT)Orphan drugstandard

Celgene Corporation

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Acute myeloid leukemia and myelodysplastic syndromes related to radiation.
Search all trials →
Search clinical trials for Acute myeloid leukemia and myelodysplastic syndromes related to radiation

Recent News & Research

No recent news articles indexed yet for Acute myeloid leukemia and myelodysplastic syndromes related to radiation.
Search PubMed for Acute myeloid leukemia and myelodysplastic syndromes related to radiation

Browse all Acute myeloid leukemia and myelodysplastic syndromes related to radiation news →

Specialist Network

Top 2 by expertise

View all Acute myeloid leukemia and myelodysplastic syndromes related to radiation specialists →

Quick Actions